MAIA-2022-12

N/A

Report date: 2024/08/30 11:36:11
NME

Base Information

Drug NameMAIA-2022-12
Drug Alias NameMAIA-2022-12MAIA-2022-012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell death stimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMAIA Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesMAIA Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A